Climb Bio (CLYM) Other Accumulated Expenses (2021 - 2026)

Climb Bio has reported Other Accumulated Expenses for 6 years, with the latest figure at $113000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Accumulated Expenses fell 88.7% year-over-year to $113000.0; the trailing twelve-month figure through Mar 2026 stood at $113000.0 (down 88.7% YoY), and the FY2025 full-year result was $59000.0, down 33.71% from the prior year.
• Other Accumulated Expenses for Q1 2026 stood at $113000.0, up from $59000.0 in the prior quarter.
• The five-year high for Other Accumulated Expenses was $1.0 million in Q1 2025, with the low at $22000.0 in Q3 2024.
• Historically, Other Accumulated Expenses has averaged $210454.5 across 5 years, with a median of $113000.0 in 2026.
• Annual changes were most pronounced in 2025 — Other Accumulated Expenses jumped 250.0% — and 2026, when it sank 88.7%.
• Climb Bio's Other Accumulated Expenses stood at $245000.0 in 2022, then plunged by 43.67% to $138000.0 in 2023, then slumped by 35.51% to $89000.0 in 2024, then sank by 33.71% to $59000.0 in 2025, then surged by 91.53% to $113000.0 in 2026.
• The last three Other Accumulated Expenses figures came in at $113000.0 (Q1 2026), $59000.0 (Q4 2025), and $77000.0 (Q3 2025), per Business Quant data.